News Image

Evofem Biosciences Announces Financial Results for the First Quarter of 2024

Provided By PR Newswire

Last update: May 15, 2024

SAN DIEGO, May 15, 2024 /PRNewswire/ -- The company behind the hormone-free contraceptive Phexxi® (lactic acid, citric acid and potassium bitartrate), Evofem Biosciences, Inc. ("Evofem" or "the Company") (OTCQB: EVFM) today announced financial results for the first quarter of 2024. Highlights of and since the quarter include:

Read more at prnewswire.com

ADITXT INC

NASDAQ:ADTX (7/24/2025, 1:21:20 PM)

1.25

+0.02 (+1.63%)



Find more stocks in the Stock Screener

Follow ChartMill for more